Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFNH BioForce Nanosciences	$0.80	$0.65	$0.33 ▼ $1.44	$26.83M	-1.11	563 shs	N/A
INTT inTEST	$7.00 +4.0%	$7.19	$5.24 ▼ $9.77	$87.35M	1.55	37,279 shs	72,785 shs
NAUT Nautilus Biotechnology	$0.70 +4.9%	$0.74	$0.66 ▼ $3.09	$88.54M	1.42	199,094 shs	165,470 shs
PRE Prenetics Global	$7.25 -0.5%	$8.02	$3.09 ▼ $11.99	$94.14M	0.15	32,320 shs	147,656 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFNH BioForce Nanosciences	0.00%	-6.91%	+6.73%	+60.09%	-19.14%
INTT inTEST	0.00%	+2.19%	-3.31%	+16.28%	-4.37%
NAUT Nautilus Biotechnology	0.00%	-1.63%	-7.88%	-4.25%	-71.15%
PRE Prenetics Global	0.00%	-4.61%	-10.05%	-29.68%	+25.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFNH BioForce Nanosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INTT inTEST	2.5818 of 5 stars	3.3	4.0	0.0	0.0	0.0	1.7	1.3
NAUT Nautilus Biotechnology	2.0554 of 5 stars	2.5	3.0	0.0	0.0	0.6	4.2	0.6
PRE Prenetics Global	1.7249 of 5 stars	2.5	4.0	0.0	0.0	1.3	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFNH BioForce Nanosciences	0.00	N/A	N/A	N/A
INTT inTEST	2.67	Moderate Buy	$12.00	71.43% Upside
NAUT Nautilus Biotechnology	1.00	Sell	$2.13	203.14% Upside
PRE Prenetics Global	3.00	Buy	$9.00	24.14% Upside

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFNH BioForce Nanosciences	N/A	N/A	N/A	N/A	($0.01) per share	N/A
INTT inTEST	$121.64M	0.72	$1.22 per share	5.75	$7.92 per share	0.88
NAUT Nautilus Biotechnology	N/A	N/A	N/A	N/A	$1.43 per share	N/A
PRE Prenetics Global	$30.62M	3.07	N/A	N/A	$13.20 per share	0.55

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFNH BioForce Nanosciences	-$490K	-$0.04	N/A	∞	N/A	N/A	N/A	-30,300.56%	11/6/2025 (Estimated)
INTT inTEST	$9.34M	-$0.07	30.44	17.50	N/A	2.33%	5.31%	3.42%	N/A
NAUT Nautilus Biotechnology	-$70.78M	-$0.52	N/A	N/A	N/A	N/A	-32.53%	-27.85%	10/28/2025 (Estimated)
PRE Prenetics Global	-$46.30M	-$3.99	N/A	N/A	N/A	-115.91%	-28.07%	-22.27%	10/6/2025 (Estimated)

Latest BFNH, PRE, NAUT, and INTT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/31/2025	Q2 2025	NAUT Nautilus Biotechnology	-$0.14	-$0.12	+$0.02	-$0.12	N/A	N/A
6/12/2025	Q1 2025	PRE Prenetics Global	N/A	-$0.80	N/A	-$0.80	N/A	$17.31 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFNH BioForce Nanosciences	N/A	N/A	N/A	N/A	N/A
INTT inTEST	N/A	N/A	N/A	N/A	N/A
NAUT Nautilus Biotechnology	N/A	N/A	N/A	N/A	N/A
PRE Prenetics Global	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFNH BioForce Nanosciences	N/A	N/A	N/A
INTT inTEST	0.08	2.26	1.38
NAUT Nautilus Biotechnology	N/A	18.52	18.52
PRE Prenetics Global	N/A	2.07	1.89

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFNH BioForce Nanosciences	N/A
INTT inTEST	63.18%
NAUT Nautilus Biotechnology	50.71%
PRE Prenetics Global	25.01%

Insider Ownership

Company	Insider Ownership
BFNH BioForce Nanosciences	39.54%
INTT inTEST	7.00%
NAUT Nautilus Biotechnology	41.10%
PRE Prenetics Global	7.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFNH BioForce Nanosciences	2	33.52 million	20.27 million	Not Optionable
INTT inTEST	320	12.48 million	11.69 million	Optionable
NAUT Nautilus Biotechnology	130	126.31 million	74.39 million	Optionable
PRE Prenetics Global	1	12.98 million	11.97 million	Not Optionable

BFNH, PRE, NAUT, and INTT Headlines

Recent News About These Companies

Prenetics Global Divests ACT Genomics Stake and Invests in Bitcoin

August 22 at 8:50 AM | tipranks.com

Prenetics Global (NASDAQ:PRE) Trading Up 1.8% - Should You Buy?

August 21 at 3:04 AM | marketbeat.com

Prenetics Approves Major Share Capital Increase at August 2025 Meeting

August 1, 2025 | tipranks.com

Prenetics Global (NASDAQ:PRE) Shares Up 0.5% - Here's Why

July 29, 2025 | marketbeat.com

Prenetics Global Limited (PRE) Earnings Surprise Summary (EPS ...

July 25, 2025 | seekingalpha.com

Prenetics Global Limited Adopts Bitcoin Treasury Strategy Amidst Market Volatility

July 17, 2025 | tipranks.com

PRE Prenetics Global Limited - Seeking Alpha

July 9, 2025 | seekingalpha.com

Prenetics Global Limited (PRE) - Yahoo Finance

June 30, 2025 | finance.yahoo.com

Aryna Sabalenka Adds Her Muscle to IM8 as Ambassador & Shareholder

June 30, 2025 | msn.com

Aryna Sabalenka Becomes First Current Athlete Shareholder in Prenetics' IM8 Supplements Brand

June 26, 2025 | quiverquant.comQ

World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

June 26, 2025 | globenewswire.com

Cardone Capital goes all-in on Bitcoin adding 1K BTC to its reserve

June 23, 2025 | msn.com

$1.24 Billion in Bitcoin Added to Corporate Treasuries This Week

June 22, 2025 | coingape.comC

A South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin Treasury

June 21, 2025 | coindesk.com

Healthcare Meets Crypto: David Beckham–Backed Prenetics Launches $20M Bitcoin Treasury

June 20, 2025 | techstory.inT

Prenetics Global (NASDAQ:PRE) Stock, Short Interest Report

June 19, 2025 | benzinga.com

Prenetics Adopts $20M Bitcoin Treasury Strategy

June 19, 2025 | thecurrencyanalytics.comT

Prenetics Global First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line

June 19, 2025 | finance.yahoo.com

Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board

June 18, 2025 | globenewswire.com

Prenetics Global Limited Divests ACT Genomics, Strengthens Financial Position and Raises FY2025 Revenue Outlook

June 18, 2025 | quiverquant.comQ

Prenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million Transaction

June 18, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BFNH, PRE, NAUT, and INTT Company Descriptions

BioForce Nanosciences OTCMKTS:BFNH

$0.80 0.00 (0.00%)

As of 08/22/2025

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

inTEST NYSE:INTT

$7.00 +0.27 (+4.01%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$7.04 +0.04 (+0.50%)

As of 08/22/2025 04:10 PM Eastern

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies. The Electronic Test segment offers in2, Cobal, and LS series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products, which protect the interface contacts and ensure proper repeatable and precise alignment between the test head's interface board and the prober's probing assembly. This segment also provides tester interfaces that offer electrical connections between the tester and the wafer prober or IC handler; scorpion flying probe test systems that designs and manufactures robotics-based electronic test equipment; and BRiZ automated test and programming services. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The Environmental Technologies segment provides ThermoStream products that are used in the semi market as a stand-alone temperature management tool, or in various electronic test applications; thermal chambers; thermal platforms; Thermonics temperature conditioning products that offer tempered gas or fluid; and ultra-cold storage solutions, including biomedical freezers, refrigerators, and mobile storage solutions. The Process Technologies segment offers EKOHEAT and EASYHEAT induction heating systems; and digital streaming and image capturing solutions. The company markets and sells its products to semiconductor manufacturers, third-party foundries, test and assembly providers, and original equipment manufacturers. inTEST Corporation was incorporated in 1981 and is headquartered in Mount Laurel, New Jersey.

Nautilus Biotechnology NASDAQ:NAUT

$0.70 +0.03 (+4.91%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$0.70 0.00 (0.00%)

As of 08/22/2025 06:02 PM Eastern

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Prenetics Global NASDAQ:PRE

$7.25 -0.04 (-0.55%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$7.24 0.00 (-0.07%)

As of 08/22/2025 04:10 PM Eastern

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time